Growth Metrics

Thermo Fisher Scientific (TMO) Consolidated Net Income (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Consolidated Net Income readings, the most recent being $1.7 billion for Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 9.11% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $6.9 billion, a 4.61% increase, with the full-year FY2025 number at $6.8 billion, up 5.97% from a year prior.
  • Consolidated Net Income hit $1.7 billion in Q1 2026 for Thermo Fisher Scientific, down from $2.0 billion in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $2.2 billion in Q2 2022 to a low of $1.3 billion in Q1 2024.
  • Median Consolidated Net Income over the past 5 years was $1.6 billion (2025), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Consolidated Net Income: crashed 41.18% in 2023 and later rose 18.8% in 2024.
  • Thermo Fisher Scientific's Consolidated Net Income stood at $1.6 billion in 2022, then rose by 0.19% to $1.6 billion in 2023, then rose by 11.45% to $1.8 billion in 2024, then increased by 11.67% to $2.0 billion in 2025, then fell by 16.8% to $1.7 billion in 2026.
  • The last three reported values for Consolidated Net Income were $1.7 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.6 billion (Q3 2025) per Business Quant data.